Its dual receptor activity suggests potential advantages in metabolic regulation, but more extensive clinical data are needed to confirm its safety and effectiveness
BPC-157, or Body Protecting Compound-157, is a 15-amino-acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) isolated from gastric juices.[1][2] It was first identified in the 1990s as part of research into cytoprotective agents that safeguard the gastrointestinal (GI) tract from damage.[3] Unlike many peptides, BPC-157 is highly stable in acidic environments, allowing for oral administration without significant degradation.[4] In compounding pharmacies, BPC-157 is often prepared as capsules, injectables, or topical formulations
Each serving delivers 30 mg of bioavailable zinc combined with PerfectAmino EAAs, offering comprehensive support for cellular defense, skin health, immune resilience, and overall metabolic function.*
It showed that this pathway could be targeted for cancer immunotherapy [1]
